Changes in brain Glx in depressed bipolar patients treated with lamotrigine: a proton MRS study
<strong>Background</strong> Lamotrigine is a useful treatment in bipolar depression but requires several weeks of dose titration before its clinical effects can be assessed. Animal experimental studies suggest that lamotrigine lowers glutamate release. The aim of the current study was to...
Auteurs principaux: | Godlewska, B, Emir, U, Masaki, C, Bargiotas, T, Cowen, P |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2018
|
Documents similaires
-
Brain glutamate in medication-free depressed patients: A proton MRS study at 7 Tesla
par: Godlewska, B, et autres
Publié: (2017) -
Imaging Brain Glx Dynamics in Response to Pressure Pain Stimulation: A 1H-fMRS Study
par: Luke A. Jelen, et autres
Publié: (2021-07-01) -
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy
par: Taylor, M, et autres
Publié: (2008) -
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.
par: Taylor, M, et autres
Publié: (2008) -
Functional connectivity between task-positive networks and the left precuneus as a biomarker of response to lamotrigine in bipolar depression: a pilot study
par: Martens, M, et autres
Publié: (2021)